Assessment of hepatic VX2 tumors with combined percutaneous transhepatic lymphosonography and contrast-enhanced ultrasonographic imaging

World Journal of Gastroenterology

Volumn 14, Issue 24, 2008, Pages 3908-3913

  Liu, Cun ^a   Liang, Ping ^b   Wang, Yang ^b   Zhou, Pei ^b   Li, Xin ^b   Han, Zhi Yu ^b   Liu, Shao Ping ^a  

^a SHANDONG UNIVERSITY   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Contrast enhanced ultrasonographic imaging; Percutaneous transhepatic lymphosonography; Ultrasound; Ultrasound contrast media; VX2 tumor

Indexed keywords

SONOVUE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ECHOGRAPHY; EXPERIMENTAL RABBIT; IMAGE ANALYSIS; IMAGE PROCESSING; INTERMETHOD COMPARISON; LIVER PARENCHYMA; LIVER TUMOR; LYMPH VESSEL; LYMPHANGIOGENESIS; LYMPHATIC SYSTEM EXAMINATION; MALE; NONHUMAN; PERCUTANEOUS TRANSHEPATIC CHOLANGIOGRAPHY; TUMOR VOLUME;

EID: 54349087370     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.14.3908     Document Type: Article

References (40)

1. Maruyama H, Matsutani S, Saisho H, Mine Y, Kamiyama N, Hirata, T, Sasamata, M. Real-time blood-pool images of contrast enhanced ultrasound with Definity in the detection of tumour nodules in the liver. Br J Radiol 2005; 78: 512-518
2. McDonald DM, Choyke PL. Imaging of angiogenesis: from microscope to clinic. Nat Med 2003; 9: 713-725
3. Stewart VR, Sidhu PS. New directions in ultrasound: microbubble contrast. Br J Radiol 2006: 79: 189-194
4. Bloch SH, Dayton PA, Ferrara KW. Targeted imaging using ultrasound contrast agents. Progess and opportunities for clinical and research applications. IEEE Eng Med Biol Mag 2004:23: 18-29
5. Nicolau C, Catala V, Vilana R, Gilabert R, Bianchi L, Sofe M, Pages M, Bru C. Evaluation of hepatocellular carcinoma using SonoVue, a second generation ultrasound contrast agent: correlation with cellular differentiation. Eur Radiol 2004; 14: 1092-1099
6. Cosgrove D. Future prospects for SonoVue and CPS. Eur Radiol 244; 14 Suppl 8: P116-P124
7. Hettiarachchi K, Talu E, Longo ML, Dayton PA, Lee AP. On-chip generation of microbubbles as a practical technology for manufacturing contrast agents for ultrasonic imaging. Lab Chip 2007; 7: 463-468
8. Zhao S, Kruse DE, Ferrara KW, Dayton PA. Selective imaging of adherent targeted ultrasound contrast agents. Phys Med Biol 2007, 52: 2055-2072
9. Lindner JR. Microbubbles in medical imaging: current applications and future directions. Nat Rev Drug Discor 2004; 3: 527-532
10. Zhang XH, Huang DP, Guo GL, Chen GR, Zhang HX, Wan L, Chen SY. Coexpression of VEGF-C and COX-2 and its association with lymphangiogenesis in human breast cancer. BMC Cancer 2008; 8: 4
11. Choi SH, Kono Y, Corbeil J, Lucidarme O, Mattroy RF. Model to quantify lymph node enhancement on indirect sonographic lymphography. AJR Am J Roentgenol 2004; 183: 513-517
12. Mattrey RF, Kono Y, Baker K, Peterson T. Sentinel lymph node imaging with microbubble ultrasound contrast material. Acad Radiol 2002; 9 Suppl 1: S231-S235
13. Omoto K, Mizunuma H, Ogura S, Hozumi Y, Nagai H, Taniguchi N, Itoh K. New method of sentinel node identification with ultrasonography using albumin as contrast agent: a study in pigs. Ultrasound Med Biol 2002; 28: 1115-1122
14. Goldberg BB, Merton DA, Liu JB, Thakur M, Murphy GF, Needleman L, Tornes A, Forsberg F. Sentinel lymph nodes in a swine model with melanoma: contrast-enhanced lymphatic US. Radiology 2004; 230: 727-734
15. Omoto K, Hozumi-Y, Omoto Y, Taniguchi N, Itoh K, Fujii Y, Mizunuma H, Nagai H. Sentinel node detection in breast cancer using contrast-enhanced sonography with 25% albumin-Initial clinical experience. J Clin Ultrasound 2006; 34: 317-326
16. National Research Council. Guide for the care and use of laboratorv animals. 7th ed. Washington, DC: National Academy Press: 1996: 321 Available from: URL: http://www.nap.edu/readingroom/books/ labrats/
17. Hauff P, Fritzsch T, Reinhardt M, Weitschies W, Luders F, Uhlendorf V, Heldmann D. Delineation of experimental liver tumors in rabbits by a new ultrasound contrast agent and stimulated acoustic emission. Invest Radiol 1997; 32: 94-99
18. McCarville MB, Streck CJ, Dickson PV, Li CS, Nathwani AC, Davidoff AM. Angiogenesis inhibitors in a murine neuroblastoma model: quantitative assessment of intratumoral blood flow with contrast-enhanced gray-scale US. Radiology 2006; 240: 73-81
19. Palmowski M, Morgenstern B, Hauff P, Reinhardt M, Huppert J, Maurer M, Woenne EC, Doerk S, Ladewig G, Jenne JW, Delorme S, Grenacher L, Hallscheidt P, Kauffmann GW, Semmler W, Kiessling F. Pharmacodynamics of streptavidin-coated cyanoacrylate microbubbles designed for molecular ultrasound imaging. Invest Radiol 2008; 43: 162-169
20. Willmann JK, Paulmurugan R, Chen K, Gheysens O, Rodriguez-Porcel M, Lutz AM, Chen IY, Chen X, Gambhir SS. US imaging of tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice. Radiology 2008; 246: 508-518
21. Rychak JJ, Graba J, Cheung AM, Mystry BS, Lindner JR, Kerbel RS, Foster FS. Microultrasound molecular imaging of vascular endothelial growth factor receptor 2 in a mouse model of tumor angiogenesis. Mol Imaging 2007, 6: 289-296
22. Lyshchik A, Fleischer AC, Huamani J, Hallahan DE, Brissova M, Gore JC. Molecular imaging of vascular endothelial growth factor receptor 2 expression using targeted contrast-enhanced high-frequency ultrasonography. J Ultrasound Med 2007; 26: 1575-1586
23. Wang Z, Tang J, An L, Wang W, Luo Y, Li J, Xu J. Contrast-enhanced ultrasonography for assessment of tumor vascularity in hepatocellular carcinoma. J Ultrasound Med 2007; 26: 757-762
24. Makinen T, Alitalo K. Lymphangiogenesis in development and disease. Novartis Found Symp 2007; 283: 87-98; discussion 98-105, 238-241
25. Thelen A, Scholz A, Benckert C, Weichert W, Dietz E, Wiedenmann B, Neuhaus P, Jonas S. Tumor-associated lymphangiogenesis correlates with lymph node metastases and prognosis in hilar cholangiocarcinoma. Ann Surg Oncol 2008; 15: 791-799
26. Sundlisaeter E, Dicko A, Sakariassen PO, Sondenaa K, Enger PO, Bjerkvig R. Lymphangiogenesis in colorectal cancer-prognostic and therapeutic aspects. Int J Cancer 2007; 121: 1401-1409
27. Schneider M, Buchler P, Giese N, Giese T, Wilting J, Buchler MW, Friess H. Role of lymphangiogenesis and lymphangiogenic factors during pancreatic cancer progression and lymphatic spread. Int J Oncol 2006; 28: 883-890
28. Seki S, Fujimura A. Three-dimensional changes in lymphatic architecture around VX2 tongue cancer-dynamic changes after administration of antiangiogenic agent. Lymphology 2003; 36: 199-208
29. Seki S, Fujimura A. Three-dimensional changes in lymphatic architecture around VX2 tongue cancer-dynamics of growth of cancer. Lymphology 2003; 36: 128-139
30. Lassau N, Roche A. [Imaging and angiogenesis: DCE-US (dynamic contrast enhanced-ultrasonography)] Bull Cancer 2007, 94 Spec No: S247-S253
31. Pollard RE, Broumas AR, Wisner ER, Vekich SV, Ferrara KW. Quantitative contrast enhanced ultrasound and CT assessment of tumor response to antiangiogenic therapy in rats. Ultrasound Med Biol 2007, 33: 235-245
32. Ikomi F, Hanna GK, Schmid-Schonbein GW. Mechanism of colloidal particle uptake into the lymphatic system: basic study with percutaneous lymphography. Radiology 1995; 196: 107-113
33. Bergqvist L, Strand SE, Persson BR. Particle sizing and biokinetics of interstitial lymphoscintigraphic agents. Semin Nucl Med 1983: 13: 9-19
34. Wolf G. Specific imaging agents for lymph nodes. In: Torchilin, VP, ed. Handbook of Targeted Delivery of Imaging Agents. Boca Raton, FL: CRC Press; 1995: 365-384. Available from: URL: http://www.amazon.com/ Handbook-Targeted-Delivery-Pharmacology-Toxicology/dp/0849383080
35. Yanagisawa K, Moriyasu F, Miyahara T, Yuki M, Iijima H. Phagocytosis of ultrasound contrast agent microbubbles by Kupffer cells. Ultrasound Med Biol 2007; 33: 318-325
36. Taylor SL, Rahim AA, Bush NL, Bamber JC, Porter CD. Targeted retroviral gene delivery using ultrasound. J Gene Med 2007; 9: 77-87
37. Dijkmans PA, Juffermans LJ, Musters RJ, van Wamel A, ten Cate FJ, van Gilst W, Visser CA, de Jong N, Kamp O. Microbubbles and ultrasound: from diagnosis to therapy. Eur J Echocardiogr 2004; 5: 245-256
38. Feinstein SB. The powerful microbubble: from bench to bedside, from intravascular indicator to therapeutic delivery system, and beyond. Am J Physiol Heart Circ Physiol 2004; 287: H450-H457
39. Rapoport N, Gao Z, Kennedy A. Multifunctional nanoparticles for combining ultrasonic tumor imaging and targeted chemotherapy. J Natl Cancer Inst 2007; 99: 1095-1106
40. Borden MA, Caskey CF, Little E, Gillies RJ, Ferrara KW. DNA and polylysine adsorption and multilayer construction onto cationic lipid-coated microbubbles. Langmuir 2007; 23: 9401-9408